These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Lewis GF; Carpentier A; Adeli K; Giacca A Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743 [TBL] [Abstract][Full Text] [Related]
3. Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance. Blaak EE Best Pract Res Clin Endocrinol Metab; 2005 Sep; 19(3):391-403. PubMed ID: 16150382 [TBL] [Abstract][Full Text] [Related]
4. Fatty acid metabolism in obesity and type 2 diabetes mellitus. Blaak EE Proc Nutr Soc; 2003 Aug; 62(3):753-60. PubMed ID: 14692611 [TBL] [Abstract][Full Text] [Related]
5. Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus. Blaak EE Proc Nutr Soc; 2004 May; 63(2):323-30. PubMed ID: 15294050 [TBL] [Abstract][Full Text] [Related]
6. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Højlund K Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125 [TBL] [Abstract][Full Text] [Related]
7. Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids. Smith U; Kahn BB J Intern Med; 2016 Nov; 280(5):465-475. PubMed ID: 27699898 [TBL] [Abstract][Full Text] [Related]
8. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle. Corpeleijn E; Saris WH; Blaak EE Obes Rev; 2009 Mar; 10(2):178-93. PubMed ID: 19207879 [TBL] [Abstract][Full Text] [Related]
9. Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes. Meex RCR; Blaak EE; van Loon LJC Obes Rev; 2019 Sep; 20(9):1205-1217. PubMed ID: 31240819 [TBL] [Abstract][Full Text] [Related]
10. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes. Bleau C; Karelis AD; St-Pierre DH; Lamontagne L Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002 [TBL] [Abstract][Full Text] [Related]
11. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)? Caldwell SH; Ikura Y; Iezzoni JC; Liu Z J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458 [TBL] [Abstract][Full Text] [Related]
17. Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation. Guillet C; Masgrau A; Walrand S; Boirie Y Obes Rev; 2012 Dec; 13 Suppl 2():51-7. PubMed ID: 23107259 [TBL] [Abstract][Full Text] [Related]
18. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Dyck DJ; Heigenhauser GJ; Bruce CR Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175 [TBL] [Abstract][Full Text] [Related]
19. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Lafontan M; Girard J Diabetes Metab; 2008 Sep; 34(4 Pt 1):317-27. PubMed ID: 18550411 [TBL] [Abstract][Full Text] [Related]
20. Insulin Resistance, Obesity and Lipotoxicity. Yazıcı D; Sezer H Adv Exp Med Biol; 2017; 960():277-304. PubMed ID: 28585204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]